| Isotretinoin | Approved Investigational | ELOVL4 | 6785 |
downregulated | Isotretinoin results in decreased expression of ELOVL4 mRNA | 6q14.1 | |
| Isotretinoin | Approved Investigational | ELOVL5 | 60481 |
downregulated | Isotretinoin results in decreased expression of ELOVL5 mRNA | 6p12.1 | |
| Isotretinoin | Approved Investigational | EMP1 | 2012 |
upregulated | Isotretinoin results in increased expression of EMP1 mRNA | 12p13.1 | |
| Isotretinoin | Approved Investigational | ERCC1 | 2067 |
downregulated | Isotretinoin results in decreased expression of ERCC1 mRNA | 19q13.32 | |
| Isotretinoin | Approved Investigational | ETFDH | 2110 |
downregulated | Isotretinoin results in decreased expression of ETFDH mRNA | 4q32.1 | |
| Isotretinoin | Approved Investigational | FA2H | 79152 |
downregulated | Isotretinoin results in decreased expression of FA2H mRNA | 16q23.1 | |
| Isotretinoin | Approved Investigational | FABP5 | 2171 |
downregulated | Isotretinoin results in decreased expression of FABP5 mRNA | 8q21.13 | |
| Isotretinoin | Approved Investigational | FABP6 | 2172 |
downregulated | Isotretinoin results in decreased expression of FABP6 mRNA | 5q33.3 | |
| Isotretinoin | Approved Investigational | FABP7 | 2173 |
downregulated | Isotretinoin results in decreased expression of FABP7 mRNA | 6q22.31 | |
| Isotretinoin | Approved Investigational | FADS1 | 3992 |
downregulated | Isotretinoin results in decreased expression of FADS1 mRNA | 11q12.2 | |
| Isotretinoin | Approved Investigational | FADS2 | 9415 |
downregulated | Isotretinoin results in decreased expression of FADS2 mRNA | 11q12.2 | |
| Isotretinoin | Approved Investigational | FAM149A | 25854 |
upregulated | Isotretinoin results in increased expression of FAM149A mRNA | 4q35.1 | |
| Isotretinoin | Approved Investigational | FAM3C | 10447 |
downregulated | Isotretinoin results in decreased expression of FAM3C mRNA | 7q31.31 | |
| Isotretinoin | Approved Investigational | FAM3C | 10447 |
upregulated | Isotretinoin results in increased expression of FAM3C mRNA | 7q31.31 | |
| Isotretinoin | Approved Investigational | FAM46C | 54855 |
downregulated | Isotretinoin results in decreased expression of FAM46C mRNA | 1p12 | |
| Isotretinoin | Approved Investigational | FAR2 | 55711 |
downregulated | Isotretinoin results in decreased expression of FAR2 mRNA | 12p11.22 | |
| Isotretinoin | Approved Investigational | FASN | 2194 |
downregulated | Isotretinoin results in decreased expression of FASN mRNA | 17q25.3 | |
| Isotretinoin | Approved Investigational | FASTK | 10922 |
downregulated | Isotretinoin results in decreased expression of FASTK mRNA | 7q36.1 | |
| Isotretinoin | Approved Investigational | FBLN1 | 2192 |
upregulated | Isotretinoin results in increased expression of FBLN1 mRNA | 22q13.31 | |
| Isotretinoin | Approved Investigational | FBP1 | 2203 |
downregulated | Isotretinoin results in decreased expression of FBP1 mRNA | 9q22.32 | |
| Isotretinoin | Approved Investigational | FBP2 | 8789 |
downregulated | Isotretinoin results in decreased expression of FBP2 mRNA | 9q22.32 | |
| Isotretinoin | Approved Investigational | FBXL7 | 23194 |
upregulated | Isotretinoin results in increased expression of FBXL7 mRNA | 5p15.1 | |
| Isotretinoin | Approved Investigational | FBXO9 | 26268 |
downregulated | Isotretinoin results in decreased expression of FBXO9 mRNA | 6p12.1 | |
| Isotretinoin | Approved Investigational | FDFT1 | 2222 |
downregulated | Isotretinoin results in decreased expression of FDFT1 mRNA | 8p23.1 | |
| Isotretinoin | Approved Investigational | FDPS | 2224 |
downregulated | Isotretinoin results in decreased expression of FDPS mRNA | 1q22 | |